Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:54:46 EDT Mon 14 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:BLUE
- BLUEBIRD BIO INC -
https://www.bluebirdbio.com/
17:54:46 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
BLUE
- Q
HALTED
4.97
28.50 3.20
May 30
Jun 02
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - All 0 today
More trades...
Time ET
Ex
Price
Change
Volume
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-02 08:34
U:BLUE
News Release
200
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
2025-05-30 08:30
U:BLUE
News Release
200
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
2025-05-27 08:30
U:BLUE
News Release
200
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
2025-05-16 16:30
U:BLUE
News Release
200
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
2025-05-14 08:30
U:BLUE
News Release
200
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
2025-05-09 08:30
U:BLUE
News Release
200
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
2025-05-05 16:00
U:BLUE
News Release
200
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
2025-04-16 08:00
U:BLUE
News Release
200
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
2025-03-28 16:15
U:BLUE
News Release
200
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
2025-02-21 07:30
U:BLUE
News Release
200
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
2024-12-08 12:30
U:BLUE
News Release
200
bluebird bio Presents Positive Long-Term Data On LYFGENIA(TM) (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition
2024-12-07 12:00
U:BLUE
News Release
200
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for beta-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
2024-12-04 16:05
U:BLUE
News Release
200
bluebird bio Announces 1-for-20 Reverse Stock Split
2024-12-04 08:47
U:BLUE
News Release
200
bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model
2024-11-14 07:00
U:BLUE
News Release
200
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
2024-11-06 16:15
U:BLUE
News Release
200
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
2024-11-05 09:05
U:BLUE
News Release
200
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
2024-10-04 16:05
U:BLUE
News Release
200
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-09-27 16:30
U:BLUE
News Release
200
bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
2024-09-24 07:00
U:BLUE
News Release
200
bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025